Guidance

Live attenuated influenza vaccine: patient group direction (PGD) template

PGD template to support the administration of live attenuated influenza vaccine (Fluenz Trivalent®) in accordance with the national seasonal influenza vaccination programme.

Applies to England

Documents

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

ճ󾱲PGDtemplate supports the administration of live attenuated influenza vaccine (LAIV) (Fluenz Trivalent®) as part of thenational seasonal influenza vaccination programme.

LAIVPGDversion 15.00 is valid from 1 September 2025 to 1 April 2026.

Practitioners must not use thisPGDtemplate until it has been authorised in Section 2. This is a legal requirement (see).

ճ󾱲PGDtemplate should be used with reference to current national guidance, theGreen Book, andfor the vaccine.

Updates to this page

Published 10 July 2024
Last updated 1 July 2025 show all updates
  1. Added version 15, see page 4 for change history.

  2. First published.

Sign up for emails or print this page